Media hub

Publishing & Events
Publishing & Events
Influencing health policy and practice, and connecting communities of academics, researchers, clinicians and funders through impactful research publications, data tools and event delivery.
What we do in Publishing & Events
The BMJ
BMJ Impact Analytics
BMJ Journals
BMJ Technology Assessment Group
British National Formulary (BNF)
Research to Publication
medRxiv
Advertising
BMJ Author Hub
Events
Podcasts
Rights & Licensing
The BMJ Collections
Partnerships
A top 10 health policy influencer >>
With 7K new or updated health and social care policy documents and clinical guidelines citing research published by BMJ Group in 2023, we are among the top ten publishers influencing health policy and practice.
Careers & Learning
Careers & Learning
Empowering health professionals worldwide throughout all career stages with exam preparation, interactive learning modules, and recruitment advertising.
What we do in Careers & Learning
BMJ Careers
BMJ Health Careers
BMJ Learning
BMJ OnExam
BMJ OnExam PACES
Partnerships
Connecting job seekers and employers in healthcare >>
See why nearly 40% of NHS Trusts subscribe to BMJ Careers
Digital health
Digital health
Supporting healthcare professionals in their decision-making providing computable, trusted, evidence-based solutions at the point of care, and clinical insights at a population level.
What we do in Digital health
BMJ Best Practice
BMJ Clinical Intelligence
Partnerships
IN THE SPOTLIGHT
Delivering the best available clinical decision support >>
BMJ Best Practice is the highest rated clinical decision support tool app in the world, rated 4.8/5 in Apple and Google Play.

Publishing & Events

Careers & Learning

Digital health

Publishing & Events

Careers & Learning

Digital health

Don’t rely on AI chatbots for accurate, safe drug information, patients warned

Harmful diagnostic errors may occur in 1 in every 14 general medical hospital patients

Global prevalence of short-sightedness in children and teens set to top 740 million cases by 2050

No major concerns about risks to offspring for would-be dads taking epilepsy meds

‘Symptom triggered’ testing can pick up early stage aggressive ovarian cancer in 1 in 4 of those affected

Lack of purpose and personal growth may precede mild cognitive impairment

Few UK people likely to be suitable for new Alzheimer’s drugs when they come on stream

Rise in global number of patient harms from 11 million to 18 million (59%) in 30 years

Few UK people likely to be suitable for new Alzheimer’s drugs when they come on stream

Rise in global number of patient harms from 11 million to 18 million (59%) in 30 years

Shared digital NHS prescribing record could avoid nearly 1 million annual drug errors

AI able to predict if and when people at high risk progress to glaucoma

Tai Chi may curb Parkinson’s disease symptoms and complications for several years

ChatGPT may be better than doctors at evidence-based management of clinical depression

Genes may be responsible for third of complex regional pain syndrome cases

Stem cell therapy can safely slow progression of relapsing-remitting MS

Strong evidence of ‘threshold effect’ for NHS 18-week waiting list target

Explore psilocybin and other psychedelics for women’s cancer distress, urge doctors

Patient aggression towards doctors’ receptionists “serious safety concern”

Aggression towards doctors’ receptionists “serious safety concern”

Products

BMJ Group

Information

Contact